2 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Glaucoma, Neovascular: new trials by email Literature Review of Glaucoma, Neovascular trials Research Report on Glaucoma, Neovascular
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG aganirsen - Ischaemic Central Retinal Vein Occlusion, Neovascular Glaucoma | Phase 2 / Phase 3 | Unknown | Gene Signal SAS | 333 | 2017-01-01 | 2016-10-31 |
| Analysis of Aqueous and Vitreous Humor Ranibizumab, No Ranibizumab - Proliferative Diabetic Retinopathy, Macular Degeneration | Phase 2 | Unknown | California Retina Consultants | 45 | 2015-07-01 | 2017-03-01 |
Macular Degeneration (1) · Retinal Perforations (1)
Eye Diseases (2) · Glaucoma (2) · Ocular Hypertension (2) · Retinal Degeneration (1) · Retinal Diseases (1)
GS 101 (1) · Ranibizumab (1)
California Retina Consultants (1) · Gene Signal SAS (1)
United States (1)
2014 (1)